Johnson & Johnson recently announced the appointment of Jessica Moore as the Group Chief Financial Officer for their Innovative Medicine division, a step reflecting the company’s focus on robust ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback